HK1254254A1 - 用於檢測骨髓增殖性疾病中calr突變的方法和組合物 - Google Patents

用於檢測骨髓增殖性疾病中calr突變的方法和組合物

Info

Publication number
HK1254254A1
HK1254254A1 HK18113398.1A HK18113398A HK1254254A1 HK 1254254 A1 HK1254254 A1 HK 1254254A1 HK 18113398 A HK18113398 A HK 18113398A HK 1254254 A1 HK1254254 A1 HK 1254254A1
Authority
HK
Hong Kong
Prior art keywords
compositions
detection
methods
myeloproliferative diseases
calr mutations
Prior art date
Application number
HK18113398.1A
Other languages
English (en)
Inventor
Y.王
D.琼斯
Original Assignee
奎斯特診斷投資股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 奎斯特診斷投資股份有限公司 filed Critical 奎斯特診斷投資股份有限公司
Publication of HK1254254A1 publication Critical patent/HK1254254A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
HK18113398.1A 2015-04-23 2018-10-18 用於檢測骨髓增殖性疾病中calr突變的方法和組合物 HK1254254A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562151742P 2015-04-23 2015-04-23
PCT/US2016/028877 WO2016172505A2 (en) 2015-04-23 2016-04-22 Methods and compositions for the detection of calr mutations in myeloproliferative diseases

Publications (1)

Publication Number Publication Date
HK1254254A1 true HK1254254A1 (zh) 2019-07-12

Family

ID=57144325

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18113398.1A HK1254254A1 (zh) 2015-04-23 2018-10-18 用於檢測骨髓增殖性疾病中calr突變的方法和組合物

Country Status (8)

Country Link
US (3) US10519509B2 (zh)
EP (1) EP3286336A4 (zh)
CN (1) CN107949643A (zh)
BR (1) BR112017022779B1 (zh)
CA (1) CA2983820A1 (zh)
HK (1) HK1254254A1 (zh)
MX (2) MX2017013623A (zh)
WO (1) WO2016172505A2 (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7189399B2 (ja) * 2017-01-18 2022-12-14 アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル 骨髄増殖性障害を患う患者の処置のための方法及び医薬組成物
CN107164474B (zh) * 2017-05-22 2020-09-04 复旦大学附属华山医院 一种检测calr基因2型突变的引物组合物及试剂盒
CN107679366A (zh) * 2017-08-30 2018-02-09 武汉古奥基因科技有限公司 一种基因组变异数据的计算方法
US20220282314A1 (en) * 2019-08-30 2022-09-08 Toyo Kohan Co., Ltd. Kit for evaluating a gene mutation related to myeloproliferative neoplasms
CN113764044B (zh) * 2021-08-31 2023-07-21 华南理工大学 一种构建骨髓增生异常综合征进展基因预测模型的方法
CN115141886B (zh) * 2022-06-28 2023-06-06 厦门艾德生物医药科技股份有限公司 一种基于高通量测序的髓系白血病基因突变检测的探针引物组及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2877013A1 (fr) 2004-10-27 2006-04-28 Assist Publ Hopitaux De Paris Indentification d'une mutation de jak2 impliquee dans la polyglobulie de vaquez
WO2011069004A1 (en) 2009-12-04 2011-06-09 Quest Diagnostics Investments Incorporated Mpl mutations in jak2 v617f negative patients with myeloproliferative disease
DK3494985T3 (da) * 2013-09-16 2021-04-19 Cemm Forschungszentrum Fuer Molekulare Medizin Gmbh Vaccinesammensætning omfattende mutant calreticulin

Also Published As

Publication number Publication date
US20160312303A1 (en) 2016-10-27
CN107949643A (zh) 2018-04-20
US20220364180A1 (en) 2022-11-17
US20200165688A1 (en) 2020-05-28
US10519509B2 (en) 2019-12-31
WO2016172505A2 (en) 2016-10-27
EP3286336A4 (en) 2018-11-14
WO2016172505A3 (en) 2016-12-08
EP3286336A2 (en) 2018-02-28
BR112017022779A2 (pt) 2018-07-17
BR112017022779B1 (pt) 2024-04-30
CA2983820A1 (en) 2016-10-27
MX2022000176A (es) 2022-02-21
MX2017013623A (es) 2018-07-06

Similar Documents

Publication Publication Date Title
IL247309A0 (en) Preparations for inhibiting virus replication and methods for their preparation and use
IL251834A0 (en) Pharmaceutical compositions containing peptide variants and methods of using them
HK1254254A1 (zh) 用於檢測骨髓增殖性疾病中calr突變的方法和組合物
PT3500255T (pt) Composições farmacêuticas oftálmicas e utilizações relacionadas com estas
RS65120B1 (sr) Farmaceutske formulacije i postupci za njihovu upotrebu
IL280690A (en) Pharmaceutical preparations that include DGLA and their use
HK1245086A1 (zh) 處方藥物組成及其製備和使用
IL248090B (en) Solid pharmaceutical preparations containing biopterin derivatives and their uses
IL266132A (en) Pharmacological formulations and methods for their preparation
ZA201703398B (en) Pharmaceutical composition and methods
HK1245085A1 (zh) 處方藥物組成及其製備和使用
HK1209346A1 (zh) 兩歧雙歧桿菌在治療或預防類風濕性關節炎或其相關疾病中的用途
HK1245113A1 (zh) 藥物組合物及其用途
HUE058749T2 (hu) Készítmények és módszerek homocisztinuria kezelésében történõ alkalmazásra
PT3233233T (pt) Composições despumantes compreendendo partículas anfifílicas e métodos de preparação e utilização das mesmas
PT3503885T (pt) Composição farmacêutica e métodos de utilização
ZA201607353B (en) Bicyclic derivatives and pharmaceutical composition including the same
IL257689B (en) Pharmaceutical preparations and methods for treating diseases related to lack of oxygen
GB201511863D0 (en) Pharmaceutical compositions comprising hexaminolevulnic acid and methods of using the same